As of May 27
| +0.0701 / +5.94%|
The 1 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 1.98, with a high estimate of 1.98 and a low estimate of 1.98. The median estimate represents a +58.40% increase from the last price of 1.25.
The current consensus among 1 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.